Lluís Cecchini - Concepedia

Author

Lluís Cecchini

Also Known As

Albert Frances, Aleksandr Vasiliev, Cecchini, Lluís, L Cecchini, L Cecchini Rosell, L L Cecchini Rosell, L. Cecchini, L. Cecchini Rosell, L. Rosell, L.L. Cecchini

141

Publications

Citations

H-Index

Concepts

All Affiliations

Universitat Pompeu Fabra Universitat Autònoma de Barcelona Hospital Del Mar Vall d'Hebron Hospital Universitari Parc de Salut

About

Lluís Cecchini is an author at Universitat Pompeu Fabra specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	605
2	Health Sciences	4	4	86
3	Applied Physiology	2	2	50
4	Athletic Training	1	1	36
5	Clinical Nutrition	1	1	26

Lluís Cecchini

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy Juan Moróte, Anna Orsola, Jacques Planas, The Journal of Urology	2007	256
Prevalence of Osteoporosis During Long-Term Androgen Deprivation Therapy in Patients with Prostate Cancer Juan Moróte, Jacques Morin, Anna Orsola, Urology Bone DiseaseUrologyMedicineProstatic DiseaseOncology	2007	182
Initial High-Grade T1 Urothelial Cell Carcinoma: Feasibility and Prognostic Significance of Lamina Propria Invasion Microstaging (T1a/b/c) in BCG-Treated and BCG-Non-Treated Patients Anna Orsola, Isabel Trias, Carles X. Raventós, European Urology Urological ResearchUrologyGenitourinary CancerMedicineBcg-non-treated Patients	2005	182
Mediterranean Dietary Pattern is Associated with Low Risk of Aggressive Prostate Cancer: MCC-Spain Study Adela Castelló, Elena Boldo, Pilar Amiano, The Journal of Urology	2017	100
Bone Mineral Density Changes in Patients With Prostate Cancer During the First 2 Years of Androgen Suppression Juan Moróte, Anna Orsola, J.M. Abascal Junquera, The Journal of Urology	2006	93
Failure to Maintain a Suppressed Level of Serum Testosterone during Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Advanced Prostate Cancer Juan Moróte, S. Esquena, J.M. Abascal Junquera, Urologia Internationalis	2006	66
Germline variation at 8q24 and prostate cancer risk in men of European ancestry Marco Matejcic, Edward J. Saunders, Tokhir Dadaev, Nature Communications	2018	58
Gender-Related Differences in Clinical and Pathological Characteristics and Therapy of Bladder Cancer Diana Puente, Núria Malats, Lluís Cecchini, European Urology Pathological CharacteristicsUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	2002	54
The relationship between daily calcium intake and bone mineral density in men with prostate cancer Jacques Planas, Juan Moróte, Anna Orsola, British Journal of Urology	2007	53
Risk factors for positive findings in patients with high‐grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette‐Guérin therapy and the decision for a repeat TUR Anna Orsola, Lluís Cecchini, Carles X. Raventós, British Journal of Urology	2009	39

Page 1